<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">molecules</journal-id>
      <journal-title>Molecules</journal-title>
      <abbrev-journal-title abbrev-type="publisher">Molecules</abbrev-journal-title>
      <abbrev-journal-title abbrev-type="pubmed">Molecules</abbrev-journal-title>
      <issn pub-type="epub">1420-3049</issn>
      <publisher>
        <publisher-name>MDPI</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3390/molecules17043805</article-id>
      <article-id pub-id-type="publisher-id">molecules-17-03805</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Protective Effect of Ischemic Postconditioning against Ischemia Reperfusion-Induced Myocardium Oxidative Injury in IR Rats</article-title>
      </title-group>
      
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Li</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>Jiangwei</given-names>
          </name>
          <xref rid="c1-molecules-17-03805" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Huajin</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff id="af1-molecules-17-03805">Department of Cardiology, Fengxian Branch of Shanghai 6th People’s Hospital, Shanghai 201400, China</aff>
      <author-notes>
        <corresp id="c1-molecules-17-03805"><label>*</label> Author to whom correspondence should be addressed; Email: <email>jwma3051@163.com</email>; Tel.: +86-137-7429-0588; Fax: +86-021-5741-2833.</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>03</month>
        <year>2012</year>
      </pub-date>
      <pub-date pub-type="collection"><month>04</month>
        <year>2012</year>
      </pub-date>
      <volume>17</volume>
      <issue>4</issue>
      <fpage>3805</fpage>
      <lpage>3817</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>03</month>
          <year>2012</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>03</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>03</month>
          <year>2012</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>©  2012 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
        <copyright-year>2012</copyright-year>
        <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
          <p>This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).</p>
        </license>
      </permissions>
      <abstract>
        <p>Brief episodes of myocardial ischemia-reperfusion (IR) employed during reperfusion after a prolonged ischemic insult may attenuate the total ischemia-reperfusion injury. This phenomenon has been termed ischemic postconditioning. In the present study, we studied the possible effect of ischemic postconditioning on an ischemic reperfusion (IR)-induced myocardium oxidative injury in rat model. Results showed that ischemic postconditioning could improve arrhythmia cordis, reduce myocardium infarction and serum creatin kinase (CK), lactate dehydrogenase (LDH) and aspartate transaminase (AST) activities in IR rats. In addition, ischemic postconditioning could still decrease myocardium malondialdehyde (MDA) level, and increased myocardium Na<sup>+</sup>-K<sup>+</sup>-ATPase, Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSH-Px) and glutathione reductase (GR) activities. It can be concluded that ischemic postconditioning possesses strong protective effects against ischemia reperfusion-induced myocardium oxidative injury in IR rats.</p>
      </abstract>
      <kwd-group>
        <kwd>ischemia-reperfusion</kwd>
        <kwd>ischemic postconditioning</kwd>
        <kwd>myocardium</kwd>
        <kwd>oxidative injury</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>1. Introduction</title>
      <p>Despite the powerful protective effects of ischemic preconditioning, the clinical application of this phenomenon has been rather disappointing, mainly because preconditioning must be instituted before the ischemic event [<xref ref-type="bibr" rid="B1-molecules-17-03805">1</xref>,<xref ref-type="bibr" rid="B2-molecules-17-03805">2</xref>,<xref ref-type="bibr" rid="B3-molecules-17-03805">3</xref>]. In contract, there is a more promising approach to cardioprotection termed “ischemic postconditioning” (IPO). Ischemic postconditioning (IPO) was described for the first time in dogs by Zhao <italic>et al</italic>. [<xref ref-type="bibr" rid="B4-molecules-17-03805">4</xref>]. These authors demonstrated that a series of repetitive cycles of brief reperfusion and reocclusion of the coronary artery applied at the onset of reperfusion after a prolonged ischemic event reduced infarct size. This finding has been confirmed in numerous investigations performed in mice [<xref ref-type="bibr" rid="B5-molecules-17-03805">5</xref>,<xref ref-type="bibr" rid="B6-molecules-17-03805">6</xref>], rats [<xref ref-type="bibr" rid="B7-molecules-17-03805">7</xref>,<xref ref-type="bibr" rid="B8-molecules-17-03805">8</xref>,<xref ref-type="bibr" rid="B9-molecules-17-03805">9</xref>], rabbits [<xref ref-type="bibr" rid="B10-molecules-17-03805">10</xref>,<xref ref-type="bibr" rid="B11-molecules-17-03805">11</xref>,<xref ref-type="bibr" rid="B12-molecules-17-03805">12</xref>,<xref ref-type="bibr" rid="B13-molecules-17-03805">13</xref>], pigs [<xref ref-type="bibr" rid="B14-molecules-17-03805">14</xref>,<xref ref-type="bibr" rid="B15-molecules-17-03805">15</xref>,<xref ref-type="bibr" rid="B16-molecules-17-03805">16</xref>], and humans [<xref ref-type="bibr" rid="B17-molecules-17-03805">17</xref>,<xref ref-type="bibr" rid="B18-molecules-17-03805">18</xref>,<xref ref-type="bibr" rid="B19-molecules-17-03805">19</xref>]. To date, different mechanisms have been associated with this cardioprotective strategy [<xref ref-type="bibr" rid="B20-molecules-17-03805">20</xref>,<xref ref-type="bibr" rid="B21-molecules-17-03805">21</xref>,<xref ref-type="bibr" rid="B22-molecules-17-03805">22</xref>], including the involvement of various G protein-coupled membrane receptors [<xref ref-type="bibr" rid="B23-molecules-17-03805">23</xref>,<xref ref-type="bibr" rid="B24-molecules-17-03805">24</xref>] and protein kinases [<xref ref-type="bibr" rid="B25-molecules-17-03805">25</xref>].</p>
      <p>In spite of the advances in myocardial protection with cardioplegia, myocardial tissue subjected to a period of ischemia undergoes morphological and functional damage, which increases during the reperfusion phase [<xref ref-type="bibr" rid="B23-molecules-17-03805">23</xref>,<xref ref-type="bibr" rid="B24-molecules-17-03805">24</xref>,<xref ref-type="bibr" rid="B25-molecules-17-03805">25</xref>,<xref ref-type="bibr" rid="B26-molecules-17-03805">26</xref>,<xref ref-type="bibr" rid="B27-molecules-17-03805">27</xref>,<xref ref-type="bibr" rid="B28-molecules-17-03805">28</xref>]. Reperfusion of ischaemic heart increases the detrimental effect of early ischemic injury by the release of reactive oxygen species (ROS). ROS sources include the electron transport chain, oxidant enzymes such as xanthine oxidase, and phagocytes. ROS may cause cellular damage by peroxidation of membrane lipids, sulfhydryl enzyme inactivation, protein cross-linking and DNA breakdown [<xref ref-type="bibr" rid="B26-molecules-17-03805">26</xref>,<xref ref-type="bibr" rid="B29-molecules-17-03805">29</xref>,<xref ref-type="bibr" rid="B30-molecules-17-03805">30</xref>,<xref ref-type="bibr" rid="B31-molecules-17-03805">31</xref>,<xref ref-type="bibr" rid="B32-molecules-17-03805">32</xref>]. To counter this potential damage, organisms have enzymatic (such as superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), catalase (CAT)) and nonenzymic (tocopherols, carotenes, ubiquinol, glutathione, ascorbic acid) antioxidant defences [<xref ref-type="bibr" rid="B27-molecules-17-03805">27</xref>,<xref ref-type="bibr" rid="B33-molecules-17-03805">33</xref>,<xref ref-type="bibr" rid="B34-molecules-17-03805">34</xref>,<xref ref-type="bibr" rid="B35-molecules-17-03805">35</xref>]. Oxidative stress occurs when there is either an over production of ROS or a decrease of antioxidant status. In this study, we investigate the protective effect of ischemic postconditioning on myocardium oxidative injury in IR rats.</p>
    </sec>
    <sec>
      <title>2. Result</title>
      <p><xref ref-type="table" rid="molecules-17-03805-t001">Table 1</xref> shows the change of the ventricular arrhythmia of control and experimental animals. The value of ventricular tachycardia threshold (VTt) and ventricular arrhythmias scores (VAS) were significantly higher in IR rats than sham operation rats. In IPO group, the value of VTt and VAS were significantly lower as compared to IR rats.</p>
      <table-wrap id="molecules-17-03805-t001" position="anchor">
        <object-id pub-id-type="pii">molecules-17-03805-t001_Table 1</object-id>
        <label>Table 1</label>
        <caption>
          <p>Effect of ischemic postconditioning on the value of VTt, VFt and VAS in IR rats.</p>
        </caption>
             <table>
          <thead>
            <tr>
              <th align="left" valign="middle">Indexs</th>
              <th align="center" valign="middle">SO</th>
              <th align="center" valign="middle">IR</th>
              <th align="center" valign="middle">IPO</th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-top: solid thin">
              <td align="left" valign="middle">VTt (s)</td>
              <td align="center" valign="middle">2.63 ± 4.61</td>
              <td align="center" valign="middle">64.53 ± 21.86 **</td>
              <td align="center" valign="middle">22.18 ± 25.15 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">VFt (s)</td>
              <td align="center" valign="middle">0</td>
              <td align="center" valign="middle">12.51 ± 20.15</td>
              <td align="center" valign="middle">0</td>
            </tr>
            <tr>
              <td align="left" valign="middle">VAS</td>
              <td align="center" valign="middle">0.62 ± 0.8</td>
              <td align="center" valign="middle">4.01 ± 1.19 **</td>
              <td align="center" valign="middle">2.43 ± 1.01 <sup>##</sup></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
        <fn>
        <p>** <italic>p</italic> &lt; 0.01, IR group <italic>vs</italic>. SO group; <sup>##</sup> <italic>p</italic> &lt; 0.01, IPO group <italic>vs</italic>. IR group. Entricular fibrillation threshold (VFt).</p>
        </fn>
        </table-wrap-foot>
      </table-wrap>
      
      <p>As shown in <xref ref-type="table" rid="molecules-17-03805-t002">Table 2</xref>, there were no significant differences in initial values (R0min) of left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEDP), and ±dp/dtmax between groups. The value of LVSP was significantly lower in IR and IPO rats than sham operation rats. In addition, the value of LVSP was significantly higher in IPO rats than IR rats. Moreover, the value of LVSP increased with extended reperfusion time in IPO rats. The value of LVEDP was significantly higher in IR and IPO rats than sham operation rats. In addition, the value of LVEDP was significantly lower in IPO rats than IR rats. The value of ±dp/dtmax was significantly lower in IR and IPO rats than sham operation rats. In addition, the value of ±dp/dtmax was significantly higher in IPO rats than IR rats.</p>
      <table-wrap id="molecules-17-03805-t002" position="anchor">
        <object-id pub-id-type="pii">molecules-17-03805-t002_Table 2</object-id>
        <label>Table 2</label>
        <caption>
          <p>Effect of ischemic postconditioning on the value of LVSP, LVEDP, and ±dp/dtmax in IR rats.</p>
        </caption>
              <table>
          <thead>
            <tr>
              <th colspan="2" align="left" valign="middle">Index</th>
              <th align="center" valign="middle">SO</th>
              <th align="center" valign="middle">IR</th>
              <th align="center" valign="middle">IPO</th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-top: solid thin">
              <td rowspan="5" align="left" valign="top">LVSP<break/>(mmHg)</td>
              <td align="left" valign="middle">Base</td>
              <td align="center" valign="middle">138.68 ± 14.29</td>
              <td align="center" valign="middle">141.05 ± 13.09</td>
              <td align="center" valign="middle">139.37 ± 12.17</td>
            </tr>
            <tr>
              <td align="left" valign="middle">R15min</td>
              <td align="center" valign="middle">136.35 ± 15.29</td>
              <td align="center" valign="middle">80.24 ± 5.92</td>
              <td align="center" valign="middle">95.11 ± 7.93</td>
            </tr>
            <tr>
              <td align="left" valign="middle">R30min</td>
              <td align="center" valign="middle">135.79 ± 11.69</td>
              <td align="center" valign="middle">86.03 ± 4.82 **</td>
              <td align="center" valign="middle">110.44 ± 12.84 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R60min</td>
              <td align="center" valign="middle">127.82 ± 13.27</td>
              <td align="center" valign="middle">87.31 ± 9.03 **</td>
              <td align="center" valign="middle">112.73 ± 13.02 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R120min</td>
              <td align="center" valign="middle">125.72 ± 11.05</td>
              <td align="center" valign="middle">69.08 ± 5.39 **</td>
              <td align="center" valign="middle">101.74 ± 12.18 <sup>##</sup></td>
            </tr>
            <tr>
              <td rowspan="5" align="left" valign="top">LVEDP<break/>(mmHg)</td>
              <td align="left" valign="middle">Base</td>
              <td align="center" valign="middle">−4.06 ± 2.31</td>
              <td align="center" valign="middle">5.13 ± 4.22 *</td>
              <td align="center" valign="middle">6.22 ± 3.17 <sup>#</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R15min</td>
              <td align="center" valign="middle">−3.21 ± 2.16</td>
              <td align="center" valign="middle">16.02 ± 8.51 **</td>
              <td align="center" valign="middle">6.03 ± 4.27 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R30min</td>
              <td align="center" valign="middle">−2.59 ± 1.62</td>
              <td align="center" valign="middle">18.39 ± 7.39 **</td>
              <td align="center" valign="middle">7.35 ± 3.02 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R60min</td>
              <td align="center" valign="middle">−1.94 ± 1.58</td>
              <td align="center" valign="middle">20.11 ± 8.92 **</td>
              <td align="center" valign="middle">7.42 ± 2.99 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R120min</td>
              <td align="center" valign="middle">−1.73 ± 2.01</td>
              <td align="center" valign="middle">23.15 ± 11.73 **</td>
              <td align="center" valign="middle">9.73 ± 3.17 <sup>##</sup></td>
            </tr>
            <tr>
              <td rowspan="5" align="left" valign="top">+dp/dtmax<break/>(mmHg/s)</td>
              <td align="left" valign="middle">Base</td>
              <td align="center" valign="middle">6,281.9 ± 2,900.5</td>
              <td align="center" valign="middle">6,301.7 ± 3,011.3</td>
              <td align="center" valign="middle">6,316.4 ± 2,794.1</td>
            </tr>
            <tr>
              <td align="left" valign="middle">R15min</td>
              <td align="center" valign="middle">5,927.1 ± 2,176.4</td>
              <td align="center" valign="middle">3,517.2 ± 1,538.9 *</td>
              <td align="center" valign="middle">4,016.3 ± 1,933.5 <sup>#</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R30min</td>
              <td align="center" valign="middle">5,827.8 ± 1,276.3</td>
              <td align="center" valign="middle">2,718.4 ± 893.2 *</td>
              <td align="center" valign="middle">4,083.2 ± 1,739.2 <sup>#</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R60min</td>
              <td align="center" valign="middle">5,628.5 ± 2,007.4</td>
              <td align="center" valign="middle">2,561.7 ± 599.2 *</td>
              <td align="center" valign="middle">4,217.3 ± 2,175.4 <sup>#</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R120min</td>
              <td align="center" valign="middle">5,513.1 ± 2,166.3</td>
              <td align="center" valign="middle">2,381.4 ± 739.1 *</td>
              <td align="center" valign="middle">3,977.2 ± 1,308.4 <sup>#</sup></td>
            </tr>
            <tr>
              <td rowspan="5" align="left" valign="top">−dp/dtmax<break/>(mmHg/s)</td>
              <td align="left" valign="middle">Base</td>
              <td align="center" valign="middle">5,132.8 ± 1,694.3</td>
              <td align="center" valign="middle">5,124.6 ± 1,352.7</td>
              <td align="center" valign="middle">5,341.7 ± 1,595.4</td>
            </tr>
            <tr>
              <td align="left" valign="middle">R15min</td>
              <td align="center" valign="middle">5,044.4 ± 1,488.6</td>
              <td align="center" valign="middle">1,984.2 ± 674.4 **</td>
              <td align="center" valign="middle">3,106.3 ± 900.5 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R30min</td>
              <td align="center" valign="middle">5,051.2 ± 1,276.4</td>
              <td align="center" valign="middle">2,264.2 ± 832.1 **</td>
              <td align="center" valign="middle">3,582.9 ± 1,254.3 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R60min</td>
              <td align="center" valign="middle">4,885.9 ± 1,366.8</td>
              <td align="center" valign="middle">2,607.5 ± 927.7 **</td>
              <td align="center" valign="middle">3,606.3 ± 846.3 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">R120min</td>
              <td align="center" valign="middle">4,633.5 ± 1,298.1</td>
              <td align="center" valign="middle">2,287.9 ± 715.6 **</td>
              <td align="center" valign="middle">3,364.7 ± 947.9 <sup>##</sup></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
        <fn>
        <p>* <italic>p</italic> &lt; 0.05, ** <italic>p</italic> &lt; 0.01, IR group <italic>vs</italic>. SO group; <sup>#</sup> <italic>p</italic> &lt; 0.05, <sup>##</sup> <italic>p</italic> &lt; 0.01, IPO group <italic>vs</italic>. IR group.</p>
        </fn>
        </table-wrap-foot>
      </table-wrap>
      
      <p>Left ventricular (LV), area at risk (AAR), AAR/LV, myocardial infarction area (MIA) and MIA/AAR in rats data for all experimental groups are shown in the <xref ref-type="table" rid="molecules-17-03805-t003">Table 3</xref> and <xref ref-type="fig" rid="molecules-17-03805-f001">Figure 1</xref>. There were no significant differences in LV, AAR, AAR/LV between IR and IPO groups. The MIA and MIA/AAR of IPO rats were considerably lower than that of IR rats.</p>
      <table-wrap id="molecules-17-03805-t003" position="anchor">
        <object-id pub-id-type="pii">molecules-17-03805-t003_Table 3</object-id>
        <label>Table 3</label>
        <caption>
          <p>Effect of ischemic postconditioning on the myocardium infarction in IR rats.</p>
        </caption>
               <table>
          <thead>
            <tr>
              <th align="left" valign="middle">Indexes</th>
              <th align="center" valign="middle">SO</th>
              <th align="center" valign="middle">IR</th>
              <th align="center" valign="middle">IPO</th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-top: solid thin">
              <td align="left" valign="middle">LV</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">525.66 ± 47.13</td>
              <td align="center" valign="middle">516.65 ± 44.57</td>
            </tr>
            <tr>
              <td align="left" valign="middle">AAR</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">259.46 ± 24.16</td>
              <td align="center" valign="middle">207.24 ± 29.11</td>
            </tr>
            <tr>
              <td align="left" valign="middle">AAR/LV (%)</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">49.64 ± 5.87</td>
              <td align="center" valign="middle">40.47 ± 4.96</td>
            </tr>
            <tr>
              <td align="left" valign="middle">MIA</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">68.24 ± 5.73</td>
              <td align="center" valign="middle">36.31 ± 3.78 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">MIA/AAR (%)</td>
              <td align="center" valign="middle">-</td>
              <td align="center" valign="middle">27.64 ± 1.98</td>
              <td align="center" valign="middle">17.68 ± 1.73 <sup>##</sup></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
        <fn>
        <p><sup>##</sup> <italic>p</italic> &lt; 0.01, IPO group <italic>vs</italic>. IR group. The area of myocardial infarction (MIA).</p>        
        </fn> 
        </table-wrap-foot>
      </table-wrap>
      
      <p><xref ref-type="table" rid="molecules-17-03805-t004">Table 4</xref> showed significant increased serum CK, LDH and AST activities in group IR as compared to the sham control group. Significant decreases in serum CK, LDH and AST activities were observed in the group of IPO rats, as compared to IR group.</p>
      
      <p><xref ref-type="table" rid="molecules-17-03805-t005">Table 5</xref> shows significantly decreased myocardium Na<sup>+</sup>-K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase activities in the IR group as compared to the sham control group. Significant increases in myocardium Na<sup>+</sup>-K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase activities were observed in the group of IPO rats, as compared to the IR group.</p>
      <fig id="molecules-17-03805-f001" position="anchor">
        <label>Figure 1</label>
        <caption>
          <p>Effects of ischemic postconditioning on infarction.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="molecules-17-03805-g001.tif"/>
      </fig>
      <table-wrap id="molecules-17-03805-t004" position="anchor">
        <object-id pub-id-type="pii">molecules-17-03805-t004_Table 4</object-id>
        <label>Table 4</label>
        <caption>
          <p>Effect of ischemic postconditioning on serum CK, LDH and AST activities in IR rats.</p>
        </caption>
              <table>
          <thead>
            <tr>
              <th align="left" valign="middle">Indexes</th>
              <th align="center" valign="middle">SO</th>
              <th align="center" valign="middle">IR</th>
              <th align="center" valign="middle">IPO</th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-top: solid thin">
              <td align="left" valign="middle">CK (U/L)</td>
              <td align="center" valign="middle">3,186.3 ± 351.6</td>
              <td align="center" valign="middle">7,319.2 ± 485.1 **</td>
              <td align="center" valign="middle">4,287.5 ± 332.8 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">LDH (U/L)</td>
              <td align="center" valign="middle">1,528.4 ± 132.7</td>
              <td align="center" valign="middle">3,328.7 ± 295.3 **</td>
              <td align="center" valign="middle">1,832.8 ± 152.7 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">AST (U/L)</td>
              <td align="center" valign="middle">251.8 ± 22.9</td>
              <td align="center" valign="middle">406.1 ± 31.8 **</td>
              <td align="center" valign="middle">298.6 ± 25.4 <sup>##</sup></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
        <fn>
        <p>** <italic>p</italic> &lt; 0.01, IR group <italic>vs</italic>. SO group; <sup>##</sup> <italic>p</italic> &lt; 0.01, IPO group <italic>vs</italic>. IR group.</p>
        </fn>
        </table-wrap-foot>
      </table-wrap>
      <table-wrap id="molecules-17-03805-t005" position="anchor">
        <object-id pub-id-type="pii">molecules-17-03805-t005_Table 5</object-id>
        <label>Table 5</label>
        <caption>
          <p>Effect of ischemic postconditioning on myocardium Na<sup>+</sup>-K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase activities in IR rats.</p>
        </caption>
                  <table>
          <thead>
            <tr>
              <th align="left" valign="middle">Indexes</th>
              <th align="center" valign="middle">SO</th>
              <th align="center" valign="middle">IR</th>
              <th align="center" valign="middle">IPO</th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-top: solid thin">
              <td align="left" valign="middle">Na<sup>+</sup>-K<sup>+</sup>-ATPase (μmol pi/mg prot/h)</td>
              <td align="center" valign="middle">7.91 ± 0.77</td>
              <td align="center" valign="middle">4.82 ± 0.51 **</td>
              <td align="center" valign="middle">7.52 ± 0.67 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase (μmol pi/mg prot/h)</td>
              <td align="center" valign="middle">8.52 ± 0.72</td>
              <td align="center" valign="middle">5.99 ± 0.46 **</td>
              <td align="center" valign="middle">7.61 ± 0.81 <sup>##</sup></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
        <fn>
        <p>** <italic>p</italic> &lt; 0.01, IR group <italic>vs</italic>. SO group; <sup>##</sup> <italic>p</italic> &lt; 0.01, IPO group <italic>vs</italic>. IR group.</p>
        </fn>
        </table-wrap-foot>
      </table-wrap>     
      <p><xref ref-type="table" rid="molecules-17-03805-t006">Table 6</xref> shows the influence of ischemic postconditioning on the levels of TBARS and the activities of myocardium SOD, CAT, GSH-Px and GR in control and experimental animals. IR rats showed significantly higher MDA levels as compared to sham control rats. IPO rats reduced the levels of lipid peroxidation markers. The activities of myocardium SOD, CAT, GSH-Px and GR were significantly lower in IR rats than in sham operation rats. Ischemic postconditioning significantly increased the activities of myocardium SOD, CAT, GSH-Px and GR in experimental animals.</p>
      <table-wrap id="molecules-17-03805-t006" position="anchor">
        <object-id pub-id-type="pii">molecules-17-03805-t006_Table 6</object-id>
        <label>Table 6</label>
        <caption>
          <p>Effect of ischemic postconditioning on the levels of TBARS and the activities of myocardium SOD, CAT, GSH-Px and GR in IR rats.</p>
        </caption>
                <table>
          <thead>
            <tr>
              <th align="left" valign="middle">Indexes </th>
              <th align="center" valign="middle">SO</th>
              <th align="center" valign="middle">IR</th>
              <th align="center" valign="middle">IPO</th>
            </tr>
          </thead>
          <tbody>
            <tr style="border-top: solid thin">
              <td align="left" valign="middle">MDA</td>
              <td align="center" valign="middle">3.28 ± 0.26</td>
              <td align="center" valign="middle">6.82 ± 0.53 **</td>
              <td align="center" valign="middle">4.13 ± 0.29 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">SOD</td>
              <td align="center" valign="middle">287.32 ± 31.73</td>
              <td align="center" valign="middle">98.41 ± 7.08 **</td>
              <td align="center" valign="middle">241.63 ± 27.56 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">CAT</td>
              <td align="center" valign="middle">28.94 ± 2.54</td>
              <td align="center" valign="middle">12.62 ± 1.42 **</td>
              <td align="center" valign="middle">25.17 ± 2.64 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">GSH-Px</td>
              <td align="center" valign="middle">37.82 ± 1.89</td>
              <td align="center" valign="middle">21.65 ± 2.65 **</td>
              <td align="center" valign="middle">34.06 ± 2.16 <sup>##</sup></td>
            </tr>
            <tr>
              <td align="left" valign="middle">GR</td>
              <td align="center" valign="middle">25.28 ± 1.66</td>
              <td align="center" valign="middle">10.63 ± 1.43 **</td>
              <td align="center" valign="middle">22.69 ± 1.98 <sup>##</sup></td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
        <fn>
        <p>** <italic>p</italic> &lt; 0.01, IR group <italic>vs</italic>. SO group; <sup>##</sup> <italic>p</italic> &lt; 0.01, IPO group <italic>vs</italic>. IR group.</p>
        </fn>
        </table-wrap-foot>
      </table-wrap>
      
    </sec>
    <sec sec-type="discussion">
      <title>3. Discussion</title>
      <p>In the present study, changes in the haemodynamic parameters supported the evidence of ischemic-reperfusion injury of the untreated rats’ hearts. Ventricular tachycardia (VT) was defined as sustained ventricular rate (absence of P wave, rapid, wide QRS complexes) greater than 1,000 beats/min with a reduction in arterial pressure below 40 mmHg. Ventricular fibrillation was defined as a ventricular rhythm without a recognizable QRS complex, in which signal morphology changed from cycle to cycle, and for which it was impossible to estimate heart rate. The value of VTt and VAS were significantly higher in IR rats than sham operation rats. This indicated that IR operation could increase ventricular tachycardia and fibrillation, exacerbate arrhythmia. In the IPO group, the value of VTt and VAS were significantly decreased. This indicated that IR operation could decrease ventricular tachycardia and fibrillation and alleviate arrhythmia. During ischemia, there was a significant fall in LVSP and LVEDP (an index for diastolic function) along with a tendency to fall of both left ventricular peak (+) dP/dt (an index for systolic function) and (−) dP/dt (an index for diastolic function). Following reperfusion, a further fall in LVSP and ±dp/dtmax was observed, along with an incomplete recovery of LVEDP. Reperfusion of the ischemic myocardium also caused a further significant reduction in both (+) and (−) dP/dt, which failed to recover during reperfusion. These indicated that IR decreased myocardium systolic and diastolic function. Similar findings have also been reported earlier [<xref ref-type="bibr" rid="B28-molecules-17-03805">28</xref>,<xref ref-type="bibr" rid="B29-molecules-17-03805">29</xref>,<xref ref-type="bibr" rid="B36-molecules-17-03805">36</xref>,<xref ref-type="bibr" rid="B37-molecules-17-03805">37</xref>]. The value of LVSP was significantly higher in IPO rats than IR rats. The value of LVEDP was significantly lower in IPO rats than IR rats. The value of ±dp/dtmax was significantly higher in IPO rats than IR rats. These results indicated that ischemic postconditioning significantly improved myocardium systolic and diastolic function in IR rats.</p>
      <p>Reperfusion of the previously ischemic myocardium can cause tissue injury [<xref ref-type="bibr" rid="B24-molecules-17-03805">24</xref>,<xref ref-type="bibr" rid="B27-molecules-17-03805">27</xref>,<xref ref-type="bibr" rid="B33-molecules-17-03805">33</xref>,<xref ref-type="bibr" rid="B36-molecules-17-03805">36</xref>,<xref ref-type="bibr" rid="B38-molecules-17-03805">38</xref>,<xref ref-type="bibr" rid="B39-molecules-17-03805">39</xref>]. Galagudza <italic>et al</italic>. [<xref ref-type="bibr" rid="B37-molecules-17-03805">37</xref>,<xref ref-type="bibr" rid="B40-molecules-17-03805">40</xref>] suggested that the IPO could reduce infarct size in IR animals. In the current investigation, we adopted the strategy of post-conditioning, and found that ischemic postconditioning could reduce myocardial infarction area (49.42 ± 3.05 in IPO group (MIA) <italic>vs.</italic> 78.13 ± 4.17 (MIA) in IR group; 21.84 ± 1.56 in IPO group (MIA/AAR) <italic>vs</italic>. 39.07 ± 1.23 (MIA/AAR) in IR group). This indicated that ischemic postconditioning could provide protective effect against IR-induced myocardial injury. This conclusion confers the former investigators’ observations [<xref ref-type="bibr" rid="B33-molecules-17-03805">33</xref>,<xref ref-type="bibr" rid="B36-molecules-17-03805">36</xref>,<xref ref-type="bibr" rid="B38-molecules-17-03805">38</xref>,<xref ref-type="bibr" rid="B39-molecules-17-03805">39</xref>]. Intracellular markers, routinely determined by laboratory testing, are certain enzymes present at high activity in the tissue. The enzymes routinely measured in the clinical laboratory for the purpose of diagnosing and monitoring myocardial infarction include creatine kinase (CK), aspartate amino transferase (sGOT or AST), and lactate dehydrogenase (LDH) [<xref ref-type="bibr" rid="B38-molecules-17-03805">38</xref>,<xref ref-type="bibr" rid="B39-molecules-17-03805">39</xref>,<xref ref-type="bibr" rid="B41-molecules-17-03805">41</xref>,<xref ref-type="bibr" rid="B42-molecules-17-03805">42</xref>]. CK, AST and/or LDH isoenzyme determinations are useful when there is question about the tissue source of elevated enzyme activity. These enzymes are present in sufficiently high content in myocardial tissue so that the death of a relatively small amount of tissue results in a substantial increase in measurable enzyme activity in serum. The relatively high content of CK, AST and LDH in cardiac tissue suggests that the measure of these enzymes activity in serum is very useful to diagnosis and monitor myocardial infarction [<xref ref-type="bibr" rid="B40-molecules-17-03805">40</xref>,<xref ref-type="bibr" rid="B41-molecules-17-03805">41</xref>,<xref ref-type="bibr" rid="B43-molecules-17-03805">43</xref>,<xref ref-type="bibr" rid="B44-molecules-17-03805">44</xref>]. In the present study, LDH, AST, CK levels in serum of IPO rats were lower than those in the IR group. Ischemic postconditioning significantly reduced the release of intracellular enzymes (CK, AST, and LDH) from ischemic hearts, indicating a protection against cell membrane damage.</p>
      <p>Na, K-ATPase (Na, K-pump) is an integral membrane protein that maintains normal physiological gradient of Na<sup>+</sup> and K<sup>+</sup> by catalyzing and transporting of these ions across the plasma membrane. The enzyme is comprised of a and b subunits, both of which are essential for ATPase and ion pumping function [<xref ref-type="bibr" rid="B42-molecules-17-03805">42</xref>,<xref ref-type="bibr" rid="B43-molecules-17-03805">43</xref>,<xref ref-type="bibr" rid="B44-molecules-17-03805">44</xref>,<xref ref-type="bibr" rid="B45-molecules-17-03805">45</xref>,<xref ref-type="bibr" rid="B46-molecules-17-03805">46</xref>,<xref ref-type="bibr" rid="B47-molecules-17-03805">47</xref>]. Additionally Na, K-ATPase acts as a signal transducer by interacting with neighboring membrane proteins. The binding of ouabain to the Na, K-pump evokes protein and lipid kinase cascades generating secondary messengers [<xref ref-type="bibr" rid="B43-molecules-17-03805">43</xref>,<xref ref-type="bibr" rid="B44-molecules-17-03805">44</xref>,<xref ref-type="bibr" rid="B46-molecules-17-03805">46</xref>,<xref ref-type="bibr" rid="B47-molecules-17-03805">47</xref>]. The Ca<sup>2+</sup>-ATPase is the major active calcium transport protein responsible for the maintenance of normal intracellular calcium levels in a variety of cell types. Maintenance of the cation gradient by Ca<sup>2+</sup>-ATPase is of fundamental importance in the control of hydration, volume, nutrient uptake and fluidity of cells, and is also essential for the contractility and excitability properties of muscles [<xref ref-type="bibr" rid="B45-molecules-17-03805">45</xref>,<xref ref-type="bibr" rid="B46-molecules-17-03805">46</xref>,<xref ref-type="bibr" rid="B48-molecules-17-03805">48</xref>,<xref ref-type="bibr" rid="B49-molecules-17-03805">49</xref>]. In the present study, myocardium Na<sup>+</sup>-K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase activities was decreased in IR rats. Our findings are in agreement with previous observations showing that the membrane abnormalities in Na<sup>+</sup>-K<sup>+</sup>-ATPase, Na<sup>+</sup>-Ca<sup>2+</sup> exchange and Ca<sup>2+</sup>-pump activities led to the occurrence of intracellular calcium overload in experimental rat models of myocardium ischemia reperfusion [<xref ref-type="bibr" rid="B47-molecules-17-03805">47</xref>,<xref ref-type="bibr" rid="B50-molecules-17-03805">50</xref>]. Significant increases in myocardium Na<sup>+</sup>-K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase activities activities were observed in the group of IPO rats, as compared to IR group. We supposed that IPO may decrease Na<sup>+</sup> to transfer into the cells, and promote its extracellular Mobile. As a result, this reduced intracellular Ca<sup>2+</sup> content.</p>
      <p>Early experimental findings have demonstrated the increased formation of oxygen-derived free radicals (oxy-radicals) in the myocardium during post-ischemic reperfusion [<xref ref-type="bibr" rid="B48-molecules-17-03805">48</xref>,<xref ref-type="bibr" rid="B49-molecules-17-03805">49</xref>,<xref ref-type="bibr" rid="B51-molecules-17-03805">51</xref>,<xref ref-type="bibr" rid="B52-molecules-17-03805">52</xref>]. Consistent with these, our findings showed that myocardial IR injury was accompanied by decreases in myocardial ATP generation capacity and antioxidant levels/activities, which are indirect indices of mitochondrial function and antioxidant status. While the decline in mitochondrial ATP generation capacity may be caused by oxidative damage on protein complexes involved in the electron transport process [<xref ref-type="bibr" rid="B50-molecules-17-03805">50</xref>,<xref ref-type="bibr" rid="B51-molecules-17-03805">51</xref>,<xref ref-type="bibr" rid="B52-molecules-17-03805">52</xref>,<xref ref-type="bibr" rid="B53-molecules-17-03805">53</xref>,<xref ref-type="bibr" rid="B54-molecules-17-03805">54</xref>,<xref ref-type="bibr" rid="B55-molecules-17-03805">55</xref>,<xref ref-type="bibr" rid="B56-molecules-17-03805">56</xref>], the inhibition of antioxidant enzymes, such as SOD, CAT, GSH-Px and GR can aggravate the myocardial oxidative injury. ROS produced with reperfusion are scavenged by the antioxidant enzymes SOD, GSH-Px, CAT and GR. We studied SOD, GSH-Px, CAT and GR to investigate the enzymatic antioxidant status of rat heart after IR. Significantly decreased activities of SOD, GSH-Px, CAT and GR were observed in the IR group in comparison with sham group. Ischemic postconditioning significantly increased the activities of myocardium SOD, CAT, GSH-Px and GR in experimental animals. This indicates that ischemic postconditioning may alleviate oxidative injury in IR rats.</p>
    </sec>
    <sec sec-type="methods">
      <title>4. Experimental</title>
      <sec>
        <title>4.1. Cardiac Ischemic Reperfusion Models</title>
        <p>Wistar rats were provided by the Fengxian Hospital Animal Lab Centre (Shanghai, China). Forty-eight rats of either sex, with body weight of 250 g ± 20 g, were randomly assigned to three groups (16 in each): sham operation group (SO group), ischemia/reperfusion group (IR group), and ischemic postconditioning group (IPO group). Before the experiment, the rats were abstained from food for 12 h but free to drink water at any time. Briefly, after nembutal anaesthesia (40 mg/kg ip), the animals were intubated and mechanical ventilation was achieved with a positive rodent respirator using atmospheric air at a tidal volume of 5 mL and a rate of about 50 breaths/minute. The heart was exposed through a left thoracotomy in the third intercostal space. A 6.0 silk non-traumatic suture was passed through the epicardial layer around the major branch of the left coronary artery, about 2 mm of its origin. A small plastic button (diameter about 5 mm) was threaded through the ligature and placed in contact with the heart. The ends were passed through small vinyl tube and exteriorized. The heart was replaced in the chest and the chest closed after removing the residual air to avoid pneumothorax. The occlusion of the artery was produced by applying tension to the ligature, and reperfusion was achieved by releasing the tension. The method is very convenient for producing ischemia/reperfusion injury in late preconditioning (24 h after the surgery and the acute preconditioning). The electrocardiogram (ECG) was monitored throughout the experiment. All intravenous applications of saline or drugs were performed through the tail vein. The surgical mortality rate of the above procedure was very low (1–3%).</p>
        <p>Rats in SO group were allowed to a continuous perfusion for 150 min. IR group rats were kept ischemic for 30 min and reperfused for 120 min. IPO group rats were maintained ischemia for 30 min, then postconditioning was performed by three cycles of 30-second reperfusion and 30-second ischemia, and finally reperfused for 120 min. </p>
      </sec>
      <sec>
        <title>4.2. Myocardial Infarct Size Determination</title>
        <p>At the end of the 24-h reperfusion period, rats were reanesthetized, the coronary artery was reoccluded at the previous site of occlusion, and the heart was excised after Evans blue perfusion. The area at risk was identified by Evans blue staining, and the infarct area was identified by 2,3,5-triphenyltetrazolium chloride (TTC) staining. The area at risk was identified as the nonblue region and expressed as a percentage of the left ventricle area. The infarcted area was identified as the TTC-negative zone and expressed as a percentage of the area at risk.</p>
      </sec>
      <sec>
        <title>4.3. Tissue Preparation</title>
        <p>Fresh ventricular tissues were placed in medium containing (in mM): 220 mannitol, 70 sucrose, 10 HEPES, 1 EGTA, 1 PMSF, 1 sodium orthovanadate, 5 sodium fluoride, and 1 Na<sub>2</sub> β-glycerol phosphate (Sigma-Aldrich, St. Louis, MO, USA), with 5 μL/mL of protease inhibitor cocktail, pH 7.4 at 4 °C. The tissues were scissor minced and homogenized on ice with a Teflon Potter homogenizer. The homogenate was centrifuged at 17,600 g for 30 min at 4 °C to collect the cytosol.</p>
      </sec>
      <sec>
        <title>4.4. Biochemical Analysis</title>
        <p>CK, LDH, AST in blood were measured using commercially available kits.</p>
        <p>Na<sup>+</sup>-K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-Mg<sup>2+</sup>-ATPase activities were assayed by spectrophotometrically measuring the amount of inorganic phosphate liberated following incubation of the tissue extract with disodium ATP (Sigma, Welwyn Garden City, UK) as in previous studies [<xref ref-type="bibr" rid="B54-molecules-17-03805">54</xref>,<xref ref-type="bibr" rid="B57-molecules-17-03805">57</xref>]. </p>
        <p>The lipid peroxidation level in heart homogenate was measured as MDA which is the end product of lipid peroxidation, and reacts with thiobarbituric acid (TBA) as a TBA reactive substance (TBARS) to produce a red coloured complex which has peak absorbance at 532 nm according to Buege and Aust [<xref ref-type="bibr" rid="B55-molecules-17-03805">55</xref>,<xref ref-type="bibr" rid="B58-molecules-17-03805">58</xref>]. A total of 125 mL of supernatants were homogenized by sonication with TBS (50 mL), TCA-BHT (butylhydroxytoluene, 125 mL) in order to precipitate proteins and then centrifuged (1,000 g, 10 min, 4 °C). In total, 200 mL of supernatant were mixed with HCl (40 mL, 0.6 M) and TBA dissolved in Tris (160 mL, 0.7 M) and the mixture was heated at 80 °C for 10 min. The absorbance of the resultant supernatant was read at 530 nm. The amount of TBARS was calculated by using an extinction coefficient of 156 mM<sup>−1</sup> <sup>cm−1</sup>.</p>
        <p>SOD activity was measured according to the method of McCord and Fridowich [<xref ref-type="bibr" rid="B56-molecules-17-03805">56</xref>,<xref ref-type="bibr" rid="B59-molecules-17-03805">59</xref>], based on the production of superoxide radicals during the conversion of xanthine to uric acid by xanthine oxidase and the inhibition of cytochrome C reduction. One unit of SOD acitivity was defined as the amount of SOD that produces 50% inhibition of cytochrome C reduction. CAT and GPx activity were determined following the methods of Clairbone [<xref ref-type="bibr" rid="B57-molecules-17-03805">57</xref>,<xref ref-type="bibr" rid="B60-molecules-17-03805">60</xref>], and of Gunzler <italic>et al</italic>. [<xref ref-type="bibr" rid="B58-molecules-17-03805">58</xref>,<xref ref-type="bibr" rid="B61-molecules-17-03805">61</xref>], respectively. Glutathione reductase (GR) activity was assayed as described by Calberg and Mannervik [<xref ref-type="bibr" rid="B59-molecules-17-03805">59</xref>,<xref ref-type="bibr" rid="B62-molecules-17-03805">62</xref>], with some modifications, by measuring the oxidation of NADPH at 340 nm. The reaction mixture consisted of 0.1 M sodium phosphate buffer (pH 7.5), 1 mM EDTA, 0.63 mM NADPH and 0.15 mM GSSG.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>5. Conclusions</title>
      <p>The present study demonstrates that ischemic postconditioning can improve arrhythmia cordis, decrease myocardial necrosis and oxidative injury in IR rats. There are the limitations in the translation of rat data to humans, with respect to confounders such as species [<xref ref-type="bibr" rid="B60-molecules-17-03805">60</xref>,<xref ref-type="bibr" rid="B63-molecules-17-03805">63</xref>], age [<xref ref-type="bibr" rid="B61-molecules-17-03805">61</xref>,<xref ref-type="bibr" rid="B64-molecules-17-03805">64</xref>] and co-morbidities/co-medications [<xref ref-type="bibr" rid="B3-molecules-17-03805">3</xref>,<xref ref-type="bibr" rid="B62-molecules-17-03805">62</xref>,<xref ref-type="bibr" rid="B65-molecules-17-03805">65</xref>,<xref ref-type="bibr" rid="B66-molecules-17-03805">66</xref>,<xref ref-type="bibr" rid="B67-molecules-17-03805">67</xref>].</p>
    </sec>
   
  </body>
  <back>
     <notes>
      <title>Conflict of Interest</title>
      <p>The authors declare no conflict of interest.</p>
    </notes>
    <ref-list>
      <title>References and Notes</title>
      <ref id="B1-molecules-17-03805">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kloner</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Rezkalla</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>Preconditioning, postconditioning and their application to clinical cardiology</article-title>
          <source>Cardiovasc. Res.</source>
          <year>2006</year>
          <volume>70</volume>
          <fpage>297</fpage>
          <lpage>307</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cardiores.2006.01.012</pub-id><pub-id pub-id-type="pmid">16516180</pub-id></citation>
      </ref>
      <ref id="B2-molecules-17-03805">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hausenloy</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bøtker</surname>
              <given-names>H.E.</given-names>
            </name>
            <name>
              <surname>Davidson</surname>
              <given-names>S.M.</given-names>
            </name>
            <name>
              <surname>Downey</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Kitakaze</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Lecour</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Mentzer</surname>
              <given-names>R.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Translating novel strategies for cardioprotection: The Hatter Workshop Recommendations</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2010</year>
          <volume>105</volume>
          <fpage>677</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="doi">10.1007/s00395-010-0121-4</pub-id>
        </citation>
      </ref>
      <ref id="B3-molecules-17-03805">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwartz Longacre</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Kloner</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>A.E.</given-names>
            </name>
            <name>
              <surname>Baines</surname>
              <given-names>C.P.</given-names>
            </name>
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Braunwald</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Downey</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gibbons</surname>
              <given-names>R.J.</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New horizons in cardioprotection: Recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop</article-title>
          <source>Circulation</source>
          <year>2011</year>
          <volume>124</volume>
          <fpage>1172</fpage>
          <lpage>1179</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.032698</pub-id><pub-id pub-id-type="pmid">21900096</pub-id></citation>
      </ref>
      <ref id="B4-molecules-17-03805">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhao</surname>
              <given-names>Z.Q.</given-names>
            </name>
            <name>
              <surname>Corvera</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Halkos</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Kerendi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>N.P.</given-names>
            </name>
            <name>
              <surname>Guyton</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Vinten-Johansen</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of myocardial injury by ischemic postconditioning during reperfusion: Comparison with ischemic preconditioning</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <year>2003</year>
          <volume>285</volume>
          <fpage>H579</fpage>
          <lpage>H588</lpage>
        <pub-id pub-id-type="pmid">12860564</pub-id></citation>
      </ref>
      <ref id="B5-molecules-17-03805">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Buchert</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Feldhaus</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>No loss of cardioprotection by postconditioning in connexin 43-deficient mice</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2006</year>
          <volume>101</volume>
          <fpage>354</fpage>
          <lpage>356</lpage>
        <pub-id pub-id-type="doi">10.1007/s00395-006-0589-0</pub-id><pub-id pub-id-type="pmid">16568250</pub-id></citation>
      </ref>
      <ref id="B6-molecules-17-03805">
        <label>6.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaljusto</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Mori</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Mohammad Husain Rizvi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Galagudza</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Frantzen</surname>
              <given-names>M.L.</given-names>
            </name>
            <name>
              <surname>Valen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vaage</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning in rats and mice</article-title>
          <source>Scand. Cardiovasc. J.</source>
          <year>2006</year>
          <volume>40</volume>
          <fpage>334</fpage>
          <lpage>341</lpage>
        <pub-id pub-id-type="doi">10.1080/14017430601007587</pub-id><pub-id pub-id-type="pmid">17118823</pub-id></citation>
      </ref>
      <ref id="B7-molecules-17-03805">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kin</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Z.Q.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>H.Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>N.P.</given-names>
            </name>
            <name>
              <surname>Corvera</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Halkos</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Kerendi</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Guyton</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Vinten-Johansen</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion</article-title>
          <source>Cardiovasc. Res.</source>
          <year>2004</year>
          <volume>62</volume>
          <fpage>74</fpage>
          <lpage>85</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cardiores.2004.01.006</pub-id><pub-id pub-id-type="pmid">15023554</pub-id></citation>
      </ref>
      <ref id="B8-molecules-17-03805">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tang</surname>
              <given-names>X.L.</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Tiwari</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dawn</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Shirk</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotection by postconditioning in conscious rats is limited to coronary occlusions 45 min</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <year>2006</year>
          <volume>291</volume>
          <fpage>H2308</fpage>
          <lpage>H2317</lpage>
        <pub-id pub-id-type="doi">10.1152/ajpheart.00479.2006</pub-id><pub-id pub-id-type="pmid">16815986</pub-id></citation>
      </ref>
      <ref id="B9-molecules-17-03805">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsang</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hausenloy</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Mocanu</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning: A form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway</article-title>
          <source>Circ. Res.</source>
          <year>2004</year>
          <volume>95</volume>
          <fpage>230</fpage>
          <lpage>232</lpage>
          <pub-id pub-id-type="doi">10.1161/01.RES.0000138303.76488.fe</pub-id>
        </citation>
      </ref>
      <ref id="B10-molecules-17-03805">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Argaud</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Gateau-Roesch</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Raisky</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Loufouat</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Robert</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ovize</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning inhibits mitochondrial permeability transition</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>111</volume>
          <fpage>194</fpage>
          <lpage>197</lpage>
        <pub-id pub-id-type="doi">10.1161/01.CIR.0000151290.04952.3B</pub-id><pub-id pub-id-type="pmid">15642769</pub-id></citation>
      </ref>
      <ref id="B11-molecules-17-03805">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Couvreur</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Lucats</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Tissier</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bize</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Berdeaux</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ghaleh</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Differential effects of postconditioning on myocardial stunning and infarction: A study in conscious dogs and anesthetized rabbits</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <year>2006</year>
          <volume>291</volume>
          <fpage>H1345</fpage>
          <lpage>H1350</lpage>
        <pub-id pub-id-type="doi">10.1152/ajpheart.00124.2006</pub-id><pub-id pub-id-type="pmid">16565317</pub-id></citation>
      </ref>
      <ref id="B12-molecules-17-03805">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darling</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Jiang</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Maynard</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Whittaker</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Vinten-Johansen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Przyklenk</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning via stuttering reperfusion limits myocardial infarct size in rabbit hearts: Role of ERK1/2</article-title>
          <source>Am. J. Physiol. Heart Circ. Physiol.</source>
          <year>2005</year>
          <volume>289</volume>
          <fpage>H1618</fpage>
          <lpage>H1626</lpage>
        <pub-id pub-id-type="doi">10.1152/ajpheart.00055.2005</pub-id><pub-id pub-id-type="pmid">15937101</pub-id></citation>
      </ref>
      <ref id="B13-molecules-17-03805">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yang</surname>
              <given-names>X.M.</given-names>
            </name>
            <name>
              <surname>Proctor</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Krieg</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Downey</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M.V.</given-names>
            </name>
          </person-group>
          <article-title>Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <year>2004</year>
          <volume>44</volume>
          <fpage>1103</fpage>
          <lpage>1110</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jacc.2004.05.060</pub-id><pub-id pub-id-type="pmid">15337225</pub-id></citation>
      </ref>
      <ref id="B14-molecules-17-03805">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iliodromitis</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Georgiadis</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cohen</surname>
              <given-names>M.V.</given-names>
            </name>
            <name>
              <surname>Downey</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Bofilis</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Kremastinos</surname>
              <given-names>D.T.</given-names>
            </name>
          </person-group>
          <article-title>Protection from post-conditioning depends on the number of short ischemic insults in anesthetized pigs</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2006</year>
          <volume>101</volume>
          <fpage>502</fpage>
          <lpage>507</lpage>
        <pub-id pub-id-type="doi">10.1007/s00395-006-0606-3</pub-id><pub-id pub-id-type="pmid">16830072</pub-id></citation>
      </ref>
      <ref id="B15-molecules-17-03805">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skyschally</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>van Caster</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Boengler</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Gres</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Musiolik</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schilawa</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Ischemic postconditioning in pigs: No causal role for RISK activation</article-title>
          <source>Circ. Res.</source>
          <year>2009</year>
          <volume>104</volume>
          <fpage>15</fpage>
          <lpage>18</lpage>
        <pub-id pub-id-type="pmid">19038864</pub-id></citation>
      </ref>
      <ref id="B16-molecules-17-03805">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Musiolik</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Gedik</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Skyschally</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion</article-title>
          <source>Circ. Res.</source>
          <year>2011</year>
          <volume>109</volume>
          <fpage>1302</fpage>
          <lpage>1308</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.255604</pub-id><pub-id pub-id-type="pmid">21980124</pub-id></citation>
      </ref>
      <ref id="B17-molecules-17-03805">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Darling</surname>
              <given-names>C.E.</given-names>
            </name>
            <name>
              <surname>Solari</surname>
              <given-names>P.B.</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Furman</surname>
              <given-names>M.I.</given-names>
            </name>
            <name>
              <surname>Przyklenk</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>“Postconditioning” the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2007</year>
          <volume>102</volume>
          <fpage>274</fpage>
          <lpage>278</lpage>
          <pub-id pub-id-type="doi">10.1007/s00395-007-0643-6</pub-id>
        </citation>
      </ref>
      <ref id="B18-molecules-17-03805">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sivaraman</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Mudalagiri</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>di Salvo</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kolvekar</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Hayward</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Yap</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Keogh</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Hausenloy</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning protects human atrial muscle through the activation of the RISK pathway</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2007</year>
          <volume>102</volume>
          <fpage>453</fpage>
          <lpage>459</lpage>
        <pub-id pub-id-type="doi">10.1007/s00395-007-0664-1</pub-id><pub-id pub-id-type="pmid">17546527</pub-id></citation>
      </ref>
      <ref id="B19-molecules-17-03805">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Staat</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Rioufol</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Piot</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Cottin</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Cung</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>L’Huillier</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Aupetit</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Bonnefoy</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Finet</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Andre-Fouet</surname>
              <given-names>X.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Postconditioning the human heart</article-title>
          <source>Circulation</source>
          <year>2005</year>
          <volume>112</volume>
          <fpage>2143</fpage>
          <lpage>2148</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.105.558122</pub-id><pub-id pub-id-type="pmid">16186417</pub-id></citation>
      </ref>
      <ref id="B20-molecules-17-03805">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferdinandy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>G.F.</given-names>
            </name>
          </person-group>
          <article-title>Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning</article-title>
          <source>Pharmacol. Rev.</source>
          <year>2007</year>
          <volume>59</volume>
          <fpage>418</fpage>
          <lpage>458</lpage>
          <pub-id pub-id-type="doi">10.1124/pr.107.06002</pub-id>
        </citation>
      </ref>
      <ref id="B21-molecules-17-03805">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yellon</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Hausenloy</surname>
              <given-names>D.J.</given-names>
            </name>
          </person-group>
          <article-title>Myocardial reperfusion injury</article-title>
          <source>N. Engl. J. Med.</source>
          <year>2007</year>
          <volume>357</volume>
          <fpage>1121</fpage>
          <lpage>1135</lpage>
        <pub-id pub-id-type="doi">10.1056/NEJMra071667</pub-id><pub-id pub-id-type="pmid">17855673</pub-id></citation>
      </ref>
      <ref id="B22-molecules-17-03805">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Boengler</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Cardioprotection: Nitric oxide, protein kinases, and mitochondria</article-title>
          <source>Circulation</source>
          <year>2008</year>
          <volume>118</volume>
          <fpage>1915</fpage>
          <lpage>1919</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.108.805242</pub-id><pub-id pub-id-type="pmid">18981312</pub-id></citation>
      </ref>
      <ref id="B23-molecules-17-03805">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xi</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Zhao</surname>
              <given-names>Z.Q.</given-names>
            </name>
            <name>
              <surname>Merino</surname>
              <given-names>V.F.</given-names>
            </name>
            <name>
              <surname>Bader</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kukreja</surname>
              <given-names>R.C.</given-names>
            </name>
          </person-group>
          <article-title>Loss of myocardial ischemic postconditioning in adenosine A1 and bradykinin B2 receptors gene knockout mice</article-title>
          <source>Circulation</source>
          <year>2008</year>
          <volume>118</volume>
          <fpage>S32</fpage>
          <lpage>S37</lpage>
        <pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.107.752865</pub-id><pub-id pub-id-type="pmid">18824766</pub-id></citation>
      </ref>
      <ref id="B24-molecules-17-03805">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guo</surname>
              <given-names>H.T.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>R.H.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>L.J.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>Q.X.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Fan</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Bi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>W.</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Endogenous κ-opioid peptide mediates the cardioprotection induced by ischemic postconditioning</article-title>
          <source>J. Cardiovasc. Pharmacol.</source>
          <year>2011</year>
          <volume>58</volume>
          <fpage>207</fpage>
          <lpage>215</lpage>
          <pub-id pub-id-type="doi">10.1097/FJC.0b013e318220e37f</pub-id>
        </citation>
      </ref>
      <ref id="B25-molecules-17-03805">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsang</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Hausenloy</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Mocanu</surname>
              <given-names>M.M.</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>D.M.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning: A form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway</article-title>
          <source>Circ. Res.</source>
          <year>2004</year>
          <volume>95</volume>
          <fpage>230</fpage>
          <lpage>232</lpage>
        <pub-id pub-id-type="doi">10.1161/01.RES.0000138303.76488.fe</pub-id><pub-id pub-id-type="pmid">15242972</pub-id></citation>
      </ref>
      <ref id="B26-molecules-17-03805">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>K.B.</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>H.H.</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Rho</surname>
              <given-names>J.R.</given-names>
            </name>
          </person-group>
          <article-title>Changes in the antioxidative defensive system during open heart operations in humans</article-title>
          <source>Ann. Thorac. Surg.</source>
          <year>1994</year>
          <volume>58</volume>
          <fpage>170</fpage>
          <lpage>175</lpage>
        <pub-id pub-id-type="doi">10.1016/0003-4975(94)91094-4</pub-id><pub-id pub-id-type="pmid">8037518</pub-id></citation>
      </ref>
      <ref id="B27-molecules-17-03805">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Postconditioning: Old wine in a new bottle?</article-title>
          <source>J. Am. Coll. Cardiol.</source>
          <year>2004</year>
          <volume>44</volume>
          <fpage>1111</fpage>
          <lpage>1112</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jacc.2004.06.013</pub-id>
        </citation>
      </ref>
      <ref id="B28-molecules-17-03805">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ovize</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Baxter</surname>
              <given-names>G.F.</given-names>
            </name>
            <name>
              <surname>di Lisa</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Ferdinandy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Garcia-Dorado</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hausenloy</surname>
              <given-names>D.J.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vinten-Johansen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Yellon</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Working group of cellular biology of heart of european society of cardiology. postconditioning and protection from reperfusion injury: Where do we stand? Position paper from the working group of cellular biology of the heart of the European society of cardiology</article-title>
          <source>Cardiovasc. Res.</source>
          <year>2010</year>
          <volume>87</volume>
          <fpage>406</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="doi">10.1093/cvr/cvq129</pub-id>
        </citation>
      </ref>
      <ref id="B29-molecules-17-03805">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhun</surname>
              <given-names>L.Y.</given-names>
            </name>
            <name>
              <surname>Kirkland</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>G.M.</given-names>
            </name>
          </person-group>
          <article-title>Cellular responses to DNA damage in the absence of poly (ADP-ribose) polymerase</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <year>1998</year>
          <volume>245</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1006/bbrc.1998.8257</pub-id><pub-id pub-id-type="pmid">9535773</pub-id></citation>
      </ref>
      <ref id="B30-molecules-17-03805">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koç</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>A comparison of blood lipid levels of physical education and sports school students attending to different curriculum</article-title>
          <source>Afr. J. Pharm. Pharmacol.</source>
          <year>2010</year>
          <volume>4</volume>
          <fpage>890</fpage>
          <lpage>894</lpage>
        </citation>
      </ref>
      <ref id="B31-molecules-17-03805">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>özdağ</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Effects of short-term exercise on heart-rate blood pressure oxidative stress paraoxonase activity and lipid hydroperoxide</article-title>
          <source>Afr. J. Pharm Pharmacol.</source>
          <year>2010</year>
          <volume>4</volume>
          <fpage>658</fpage>
          <lpage>661</lpage>
        </citation>
      </ref>
      <ref id="B32-molecules-17-03805">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Almogren</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary tuberculosis associated with increased number and percentage of natural killer and B cells in the peripheral blood</article-title>
          <source>Afr. J. Microbiol. Res.</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>2048</fpage>
          <lpage>2052</lpage>
        </citation>
      </ref>
      <ref id="B33-molecules-17-03805">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>di Napoli</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Taccardi</surname>
              <given-names>A.A.</given-names>
            </name>
            <name>
              <surname>de Caterina</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Barsotti</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Pathophsiology of ischemia-reperfusion injury: Experimental data</article-title>
          <source>Ital. Heart J.</source>
          <year>2002</year>
          <volume>3</volume>
          <fpage>24</fpage>
          <lpage>28</lpage>
        <pub-id pub-id-type="pmid">11899585</pub-id></citation>
      </ref>
      <ref id="B34-molecules-17-03805">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fang</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X.-P.</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>H.-P.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q.-X.</given-names>
            </name>
          </person-group>
          <article-title>Correlation between clinicopathology and expression of heat shock protein 72 in human primary lung carcinomas</article-title>
          <source>Afr. J. Pharm. Pharmacol.</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>1310</fpage>
          <lpage>1314</lpage>
        </citation>
      </ref>
      <ref id="B35-molecules-17-03805">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gharibi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tajbakhsh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Zandi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Yaghobi</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of fluorescent in situ hybridization for rapid diagnosis of enterococcal wound infection</article-title>
          <source>Afr. J. Microbiol. Res.</source>
          <year>2010</year>
          <volume>4</volume>
          <fpage>2498</fpage>
          <lpage>2502</lpage>
        </citation>
      </ref>
      <ref id="B36-molecules-17-03805">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bolli</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Jeroudi</surname>
              <given-names>M.O.</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>S.B.</given-names>
            </name>
          </person-group>
          <article-title>Direct evidence that oxygenderived free radicals contribute to post ischemic myocardial dysfunction in the intact dog</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>4695</fpage>
          <lpage>4699</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.86.12.4695</pub-id><pub-id pub-id-type="pmid">2543984</pub-id></citation>
      </ref>
      <ref id="B37-molecules-17-03805">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maulik</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Seth</surname>
              <given-names>S.D.</given-names>
            </name>
            <name>
              <surname>Maulik</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Manchanda</surname>
              <given-names>S.C.</given-names>
            </name>
          </person-group>
          <article-title>Oxyfedrine in myocardial stunning</article-title>
          <source>Indian J. Exp. Biol.</source>
          <year>1997</year>
          <volume>35</volume>
          <fpage>1214</fpage>
          <lpage>1217</lpage>
        <pub-id pub-id-type="pmid">9567753</pub-id></citation>
      </ref>
      <ref id="B38-molecules-17-03805">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gauthaman</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Banerjee</surname>
              <given-names>S.K.</given-names>
            </name>
            <name>
              <surname>Dinda</surname>
              <given-names>A.K.</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Maulik</surname>
              <given-names>S.K.</given-names>
            </name>
          </person-group>
          <article-title><italic>Terminalia arjuna</italic> (Roxb.) protects rabbit heart against ischemic-reperfusion injury: Role of antioxidant enzymes and heat shock protein</article-title>
          <source>J. Ethnopharmacol.</source>
          <year>2005</year>
          <volume>96</volume>
          <fpage>403</fpage>
          <lpage>409</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jep.2004.08.040</pub-id>
        </citation>
      </ref>
      <ref id="B39-molecules-17-03805">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shabanzadeh</surname>
              <given-names>A.P.</given-names>
            </name>
            <name>
              <surname>Shuaib</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>C.X.</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke</article-title>
          <source>Brain Res.</source>
          <year>2005</year>
          <volume>1042</volume>
          <fpage>1</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2005.01.105</pub-id>
        </citation>
      </ref>
      <ref id="B40-molecules-17-03805">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galagudza</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kurapeev</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Minasian</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Valen</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Vaage</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Ischemic postconditioning: Brief ischemia during reperfusion converts persistent ventricular fibrillation into regular rhythm</article-title>
          <source>Eur. J. Cardiothorac. Surg.</source>
          <year>2004</year>
          <volume>25</volume>
          <fpage>1006</fpage>
          <lpage>1010</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ejcts.2004.02.003</pub-id><pub-id pub-id-type="pmid">15145002</pub-id></citation>
      </ref>
      <ref id="B41-molecules-17-03805">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Panteghini</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Cuccia</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Calarco</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Gei</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bozzetti</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Visioli</surname>
              <given-names>O.</given-names>
            </name>
          </person-group>
          <article-title>Serum enzymes in acute myocardial infarction after intracoronary thrombolysis</article-title>
          <source>Clin. Biochem.</source>
          <year>1986</year>
          <volume>19</volume>
          <fpage>294</fpage>
          <lpage>297</lpage>
        <pub-id pub-id-type="doi">10.1016/S0009-9120(86)80044-3</pub-id><pub-id pub-id-type="pmid">3769194</pub-id></citation>
      </ref>
      <ref id="B42-molecules-17-03805">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhayana</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Ralph Henderson</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Biochemical markers of myocardial damage</article-title>
          <source>Clin. Biochem.</source>
          <year>1995</year>
          <volume>28</volume>
          <fpage>1</fpage>
          <lpage>29</lpage>
        <pub-id pub-id-type="doi">10.1016/0009-9120(94)00065-4</pub-id><pub-id pub-id-type="pmid">7720223</pub-id></citation>
      </ref>
      <ref id="B43-molecules-17-03805">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Szabados</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Literati-Nagy</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Farkas</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Sumegi</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>BGP-15, a nicotinic amidoxime derivate protecting heart from ischemia reperfusion injury through modulation of poly(ADP-ribose) polymerase</article-title>
          <source>Biochem. Pharmacol.</source>
          <year>2000</year>
          <volume>59</volume>
          <fpage>937</fpage>
          <lpage>945</lpage>
        <pub-id pub-id-type="doi">10.1016/S0006-2952(99)00418-9</pub-id><pub-id pub-id-type="pmid">10692558</pub-id></citation>
      </ref>
      <ref id="B44-molecules-17-03805">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rajadurai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stanely Mainzen Prince</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats</article-title>
          <source>Toxicology</source>
          <year>2007</year>
          <volume>230</volume>
          <fpage>178</fpage>
          <lpage>188</lpage>
        <pub-id pub-id-type="doi">10.1016/j.tox.2006.11.053</pub-id><pub-id pub-id-type="pmid">17188415</pub-id></citation>
      </ref>
      <ref id="B45-molecules-17-03805">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yorozuya</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Adachi</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Dote</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Nakanishi</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Takasaki</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Arai</surname>
              <given-names>T.</given-names>
            </name>
          </person-group>
          <article-title>Enhancement of Na<sup>+</sup>, K<sup>+</sup>-ATPase and Ca<sup>2+</sup>-ATPase activities in multi-cycle ischemic preconditioning in rabbit hearts</article-title>
          <source>Eur. J. Cardiothorac. Surg.</source>
          <year>2004</year>
          <volume>26</volume>
          <fpage>981</fpage>
          <lpage>987</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ejcts.2004.06.009</pub-id><pub-id pub-id-type="pmid">15519193</pub-id></citation>
      </ref>
      <ref id="B46-molecules-17-03805">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tian</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dmitrieva</surname>
              <given-names>R.I.</given-names>
            </name>
            <name>
              <surname>Doris</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Crary</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Sondhi</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Sacktor</surname>
              <given-names>T.C.</given-names>
            </name>
            <name>
              <surname>Bergold</surname>
              <given-names>P.J.</given-names>
            </name>
          </person-group>
          <article-title>Protein kinase M zeta regulation of Na/K ATPase: A persistent neuroprotective mechanism of ischemic preconditioning in hippocampal slice cultures</article-title>
          <source>Brain Res.</source>
          <year>2008</year>
          <volume>1213</volume>
          <fpage>127</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="doi">10.1016/j.brainres.2008.03.046</pub-id>
        </citation>
      </ref>
      <ref id="B47-molecules-17-03805">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>de Souza Wyse</surname>
              <given-names>A.T.</given-names>
            </name>
            <name>
              <surname>Streck</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Worm</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Wajner</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Ritter</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Netto</surname>
              <given-names>C.A.</given-names>
            </name>
          </person-group>
          <article-title>Preconditioning prevents the inhibition of Na<sup>+</sup>, K<sup>+</sup>-ATPase activity after brain ischemia</article-title>
          <source>Neurochem. Res.</source>
          <year>2000</year>
          <volume>25</volume>
          <fpage>971</fpage>
          <lpage>975</lpage>
        <pub-id pub-id-type="doi">10.1023/A:1007504525301</pub-id><pub-id pub-id-type="pmid">10959493</pub-id></citation>
      </ref>
      <ref id="B48-molecules-17-03805">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chan</surname>
              <given-names>K.M.</given-names>
            </name>
            <name>
              <surname>Delfert</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Junger</surname>
              <given-names>K.D.</given-names>
            </name>
          </person-group>
          <article-title>A direct colorimetric assay for Ca<sup>2+</sup>-stimulated ATPase activity</article-title>
          <source>Anal. Biochem.</source>
          <year>1986</year>
          <volume>157</volume>
          <fpage>375</fpage>
          <lpage>380</lpage>
        <pub-id pub-id-type="doi">10.1016/0003-2697(86)90640-8</pub-id><pub-id pub-id-type="pmid">2946250</pub-id></citation>
      </ref>
      <ref id="B49-molecules-17-03805">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Halow</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Figueredo</surname>
              <given-names>V.M.</given-names>
            </name>
            <name>
              <surname>Shames</surname>
              <given-names>D.M.</given-names>
            </name>
            <name>
              <surname>Camacho</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Baker</surname>
              <given-names>A.J.</given-names>
            </name>
          </person-group>
          <article-title>Role of slowed Ca (<sup>2+</sup>) transient decline in slowed relaxation during myocardial ischemia</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>1999</year>
          <volume>31</volume>
          <fpage>1739</fpage>
          <lpage>1748</lpage>
        <pub-id pub-id-type="doi">10.1006/jmcc.1999.1012</pub-id><pub-id pub-id-type="pmid">10471357</pub-id></citation>
      </ref>
      <ref id="B50-molecules-17-03805">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Samouilidou</surname>
              <given-names>E.C.</given-names>
            </name>
            <name>
              <surname>Karli</surname>
              <given-names>J.N.</given-names>
            </name>
            <name>
              <surname>Levis</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Darsinos</surname>
              <given-names>J.T.</given-names>
            </name>
          </person-group>
          <article-title>The sarcolemmal Ca<sup>2+</sup>-ATPase of the ischemic-reperfused myocardium: Protective effect of hypocalcemia on calmodulin-stimulated activity</article-title>
          <source>Life Sci.</source>
          <year>1998</year>
          <volume>62</volume>
          <fpage>29</fpage>
          <lpage>36</lpage>
        <pub-id pub-id-type="pmid">9444965</pub-id></citation>
      </ref>
      <ref id="B51-molecules-17-03805">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maupoil</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Rochette</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of free radical and lipid peroxide formation during global ischemia and reperfusion in isolated perfused rat heart</article-title>
          <source>Cardiovasc. Drugs Ther.</source>
          <year>1988</year>
          <volume>2</volume>
          <fpage>615</fpage>
          <lpage>621</lpage>
        <pub-id pub-id-type="doi">10.1007/BF00054201</pub-id><pub-id pub-id-type="pmid">3154636</pub-id></citation>
      </ref>
      <ref id="B52-molecules-17-03805">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baker</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Felix</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Blinger</surname>
              <given-names>G.N.</given-names>
            </name>
            <name>
              <surname>Kalyanaraman</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Myocardial ischemia and reperfusion: Direct evidence for free radical generation by electron spin resonance spectroscopy</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <year>1988</year>
          <volume>85</volume>
          <fpage>2786</fpage>
          <lpage>2789</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.85.8.2786</pub-id><pub-id pub-id-type="pmid">2833754</pub-id></citation>
      </ref>
      <ref id="B53-molecules-17-03805">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Paradies</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Petrosillo</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Pistolese</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>di Venosa</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Serena</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ruggiero</surname>
              <given-names>F.M.</given-names>
            </name>
          </person-group>
          <article-title>Lipid peroxidation and alterations to oxidative metabolism in mitochondria isolated from rat heart subjected to ischemia and reperfusion</article-title>
          <source>Free Radic. Biol. Med.</source>
          <year>1999</year>
          <volume>27</volume>
          <fpage>42</fpage>
          <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1016/S0891-5849(99)00032-5</pub-id><pub-id pub-id-type="pmid">10443918</pub-id></citation>
      </ref>
      <ref id="B54-molecules-17-03805">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jha</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Jurma</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Lalli</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Pettus</surname>
              <given-names>E.H.</given-names>
            </name>
            <name>
              <surname>Greenamyre</surname>
              <given-names>J.T.</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Forman</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Andersen</surname>
              <given-names>J.K.</given-names>
            </name>
          </person-group>
          <article-title>Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity</article-title>
          <source>J. Biol. Chem.</source>
          <year>2000</year>
          <volume>275</volume>
          <fpage>26096</fpage>
          <lpage>26101</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M000120200</pub-id><pub-id pub-id-type="pmid">10846169</pub-id></citation>
      </ref>
      <ref id="B55-molecules-17-03805">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lesnefsky</surname>
              <given-names>E.J.</given-names>
            </name>
            <name>
              <surname>Moghaddas</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tandler</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Kerner</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hoppel</surname>
              <given-names>C.L.</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial dysfunction in cardiac disease: Ischemiareperfusion, aging, and heart failure</article-title>
          <source>J. Mol. Cell. Cardiol.</source>
          <year>2001</year>
          <volume>33</volume>
          <fpage>1065</fpage>
          <lpage>1089</lpage>
          <pub-id pub-id-type="doi">10.1006/jmcc.2001.1378</pub-id>
        </citation>
      </ref>
      <ref id="B56-molecules-17-03805">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Boengler</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
          </person-group>
          <article-title>Inhibition of mitochondrial permeability transition pore opening: The holy grail of cardioprotection</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2010</year>
          <volume>105</volume>
          <fpage>151</fpage>
          <lpage>154</lpage>
        <pub-id pub-id-type="doi">10.1007/s00395-009-0080-9</pub-id><pub-id pub-id-type="pmid">20066536</pub-id></citation>
      </ref>
      <ref id="B57-molecules-17-03805">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Y.R.</given-names>
            </name>
            <name>
              <surname>Yin</surname>
              <given-names>H.J.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Shi</surname>
              <given-names>D.Z.</given-names>
            </name>
          </person-group>
          <article-title>Effects of gross saponins of tribulus on Na~<sup>+</sup>-K~<sup>+</sup>-ATPase and Ca~(<sup>2+</sup>)-Mg~(<sup>2+</sup>)-ATPase activity and lactic acid content in hyperlipemic rats with acute myocardial infarction</article-title>
          <source>Tradit. Chin. Drug Res. Clin. Pharmacol.</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>248</fpage>
          <lpage>250</lpage>
        </citation>
      </ref>
      <ref id="B58-molecules-17-03805">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buege</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Aust</surname>
              <given-names>S.D.</given-names>
            </name>
          </person-group>
          <article-title>Microsomal lipid peroxidation</article-title>
          <source>Methods Enzymol.</source>
          <year>1984</year>
          <volume>105</volume>
          <fpage>302</fpage>
          <lpage>310</lpage>
        </citation>
      </ref>
      <ref id="B59-molecules-17-03805">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McCord</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Fridowich</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>The reduction of cytochrome c by milk xanthine oxidase</article-title>
          <source>J. Biol. Chem.</source>
          <year>1968</year>
          <volume>243</volume>
          <fpage>5753</fpage>
          <lpage>5760</lpage>
        <pub-id pub-id-type="pmid">4972775</pub-id></citation>
      </ref>
      <ref id="B60-molecules-17-03805">
        <label>60.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Clairbone</surname>
              <given-names>A.I.</given-names>
            </name>
            <name>
              <surname>Green-Wald</surname>
              <given-names>R.A.</given-names>
            </name>
          </person-group>
          <source>Handbook of Methods for Oxygen Radical Research</source>
          <publisher-name>CRC Press</publisher-name>
          <publisher-loc>Boca Raton, FL, USA</publisher-loc>
          <year>1985</year>
          <fpage>283</fpage>
        </citation>
      </ref>
      <ref id="B61-molecules-17-03805">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>D.S.</given-names>
            </name>
            <name>
              <surname>Steinbaugh</surname>
              <given-names>G.E.</given-names>
            </name>
            <name>
              <surname>Quarrie</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>F.C.</given-names>
            </name>
            <name>
              <surname>Hassan Talukder</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Zweier</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Crestanello</surname>
              <given-names>J.A.</given-names>
            </name>
          </person-group>
          <article-title>Ischemic postconditioning does not provide cardioprotection from long-term ischemic injury in isolated male or female rat hearts</article-title>
          <source>J. Surg. Res.</source>
          <year>2010</year>
          <volume>164</volume>
          <fpage>175</fpage>
          <lpage>181</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jss.2010.08.050</pub-id><pub-id pub-id-type="pmid">20934717</pub-id></citation>
      </ref>
      <ref id="B62-molecules-17-03805">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Carlberg</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Mannervik</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Purification and characterization of the flavoenzyme glutathione reductase from rat liver</article-title>
          <source>J. Biol. Chem.</source>
          <year>1975</year>
          <volume>250</volume>
          <fpage>5475</fpage>
          <lpage>5480</lpage>
        <pub-id pub-id-type="pmid">237922</pub-id></citation>
      </ref>
      <ref id="B63-molecules-17-03805">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skyschally</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>van Caster</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Iliodromitis</surname>
              <given-names>E.K.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Kremastinos</surname>
              <given-names>D.T.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Ischemic postconditioning: Experimental models and protocol algorithms</article-title>
          <source>Basic Res. Cardiol.</source>
          <year>2009</year>
          <volume>104</volume>
          <fpage>469</fpage>
          <lpage>483</lpage>
        <pub-id pub-id-type="doi">10.1007/s00395-009-0040-4</pub-id><pub-id pub-id-type="pmid">19543787</pub-id></citation>
      </ref>
      <ref id="B64-molecules-17-03805">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boengler</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Heusch</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Loss of cardioprotection with ageing</article-title>
          <source>Cardiovasc. Res.</source>
          <year>2009</year>
          <volume>83</volume>
          <fpage>247</fpage>
          <lpage>261</lpage>
        <pub-id pub-id-type="doi">10.1093/cvr/cvp033</pub-id><pub-id pub-id-type="pmid">19176601</pub-id></citation>
      </ref>
      <ref id="B65-molecules-17-03805">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abtahi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Ghazavi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Karimi</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Antimicrobial activities of ethanol extract of black grape</article-title>
          <source>Afr. J. Microbiol. Res.</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>4446</fpage>
          <lpage>4448</lpage>
        </citation>
      </ref>
      <ref id="B66-molecules-17-03805">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kouhpayeh</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Hashemi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Naderi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mozafar</surname>
              <given-names>S.H.</given-names>
            </name>
          </person-group>
          <article-title>The status of serum procalcitonin in sepsis and non-infectious systemic inflammatory response syndrome</article-title>
          <source>Afr. J. Microbiol. Res.</source>
          <year>2010</year>
          <volume>4</volume>
          <fpage>2632</fpage>
          <lpage>2634</lpage>
        </citation>
      </ref>
      <ref id="B67-molecules-17-03805">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayrullah</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Mehmet</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Mustafa</surname>
              <given-names>B.K.</given-names>
            </name>
            <name>
              <surname>Yesim</surname>
              <given-names>G.A.</given-names>
            </name>
            <name>
              <surname>Sadik</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>The effects of dialysers on some blood biochemical parameters in hemodialysis patients</article-title>
          <source>Afr. J. Pharm. Pharmacol.</source>
          <year>2011</year>
          <volume>5</volume>
          <fpage>2513</fpage>
          <lpage>2516</lpage>
        </citation>
      </ref>
    </ref-list>
    <fn-group>
    <fn>
    <p><italic>Sample Availability</italic>: Not available.</p>
    </fn>
    </fn-group>
  </back>
</article>
